KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,954,000 | -64.4% | 574,734 | -57.2% | 0.00% | -100.0% |
Q1 2018 | $5,493,000 | -30.2% | 1,343,145 | -20.6% | 0.00% | 0.0% |
Q4 2017 | $7,867,000 | -50.6% | 1,691,764 | -24.6% | 0.00% | -50.0% |
Q3 2017 | $15,923,000 | -4.9% | 2,242,664 | -3.1% | 0.00% | 0.0% |
Q2 2017 | $16,735,000 | +17.4% | 2,314,664 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $14,258,000 | -1.5% | 2,314,664 | -6.3% | 0.00% | 0.0% |
Q4 2016 | $14,475,000 | -14.0% | 2,470,164 | -22.0% | 0.00% | 0.0% |
Q3 2016 | $16,826,000 | -19.8% | 3,168,664 | 0.0% | 0.00% | -33.3% |
Q2 2016 | $20,977,000 | +105.7% | 3,168,664 | +45.1% | 0.00% | +200.0% |
Q1 2016 | $10,200,000 | -54.4% | 2,184,192 | -50.7% | 0.00% | -66.7% |
Q4 2015 | $22,354,000 | +41.7% | 4,426,492 | -1.2% | 0.00% | +50.0% |
Q3 2015 | $15,775,000 | -69.1% | 4,481,497 | -12.5% | 0.00% | -71.4% |
Q2 2015 | $51,101,000 | -25.5% | 5,120,392 | -4.9% | 0.01% | -22.2% |
Q1 2015 | $68,570,000 | +21.1% | 5,386,492 | +34.6% | 0.01% | +28.6% |
Q4 2014 | $56,612,000 | +2.6% | 4,000,792 | -0.3% | 0.01% | 0.0% |
Q3 2014 | $55,151,000 | -5.5% | 4,010,992 | +5.7% | 0.01% | -12.5% |
Q2 2014 | $58,378,000 | -6.1% | 3,795,700 | +4.0% | 0.01% | -11.1% |
Q1 2014 | $62,199,000 | +82.9% | 3,650,200 | +39.0% | 0.01% | +80.0% |
Q4 2013 | $34,008,000 | +872.8% | 2,626,100 | +461.1% | 0.01% | +400.0% |
Q2 2013 | $3,496,000 | – | 468,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |